Maximilian Regenold
- Biomedical Engineering
- Biomaterials top 10%
- Molecular Biology
- Oncology
- Pulmonary and Respiratory Medicine
- Co-authors
- Christine AllenMichael DunnePauric BanniganHoda Soleymani AbyanehMarc A. GauthierJames EvansTrevor D. McKeeDavid N. Dubins
- Topics
- Nanoparticle-Based Drug Delivery (10 papers)Nanoplatforms for cancer theranostics (5 papers)RNA Interference and Gene Delivery (3 papers)
- Journals
- The Journal of Physical Chemistry BAdvanced Drug Delivery ReviewsJournal of Controlled Release
- Partner nations
- CanadaGermanyUnited States
In The Last Decade
Maximilian Regenold
11 papers receiving 405 citations
Peers
Comparison fields: 5 of 76
- Biomedical Engineering 246
- Biomaterials 176
- Molecular Biology 116
- Oncology 50
- Pulmonary and Respiratory Medicine 49
Countries citing papers authored by Maximilian Regenold
This map shows the geographic impact of Maximilian Regenold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian Regenold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian Regenold more than expected).
Fields of papers citing papers by Maximilian Regenold
This network shows the impact of papers produced by Maximilian Regenold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian Regenold. The network helps show where Maximilian Regenold may publish in the future.
Co-authorship network of co-authors of Maximilian Regenold
This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian Regenold. A scholar is included among the top collaborators of Maximilian Regenold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian Regenold. Maximilian Regenold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 19 | |
| 6 | 61 | |
| 7 | 39 | |
| 8 | 84 | |
| 9 | 111 | |
| 10 | 14 | |
| 11 | 25 | |
| 12 | 45 |
About Maximilian Regenold
Maximilian Regenold is a scholar working on Biomaterials, Physical and Theoretical Chemistry and Pharmaceutical Science, having authored 12 papers that have together received 410 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Nanoplatforms for cancer theranostics (5 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Biomaterials (176 citations), Biomedical Engineering (246 citations) and Pharmaceutical Science (25 citations). Maximilian Regenold has collaborated with scholars based in Canada, Germany and United States. Frequent co-authors include Christine Allen, Michael Dunne, Pauric Bannigan, Hoda Soleymani Abyaneh, Marc A. Gauthier, James Evans, Trevor D. McKee, David N. Dubins, Michael Temple and Adam C. Waspe. Their work appears in journals such as The Journal of Physical Chemistry B, Advanced Drug Delivery Reviews and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.